This seems like such an easy win for them, hopefully they see the value
The big problem is that I want prescription-level HAs and the regulatory apparatus around this is complex enough that they probably don’t want to bother.
The big problem is that I want prescription-level HAs and the regulatory apparatus around this is complex enough that they probably don’t want to bother.